Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Income towards Parent Company: 2017-2025

Historic Income towards Parent Company for Cidara Therapeutics (CDTX) over the last 9 years, with Sep 2025 value amounting to -$83.2 million.

  • Cidara Therapeutics' Income towards Parent Company fell 18396.22% to -$83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.4 million, marking a year-over-year decrease of 2564.97%. This contributed to the annual value of $464,000 for FY2024, which is 78.41% down from last year.
  • Per Cidara Therapeutics' latest filing, its Income towards Parent Company stood at -$83.2 million for Q3 2025, which was down 223.64% from -$25.7 million recorded in Q2 2025.
  • Over the past 5 years, Cidara Therapeutics' Income towards Parent Company peaked at $14.2 million during Q3 2022, and registered a low of -$83.2 million during Q3 2025.
  • Moreover, its 3-year median value for Income towards Parent Company was -$450,000 (2024), whereas its average is -$10.8 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 178.78% in 2022, then tumbled by 18,396.22% in 2025.
  • Quarterly analysis of 5 years shows Cidara Therapeutics' Income towards Parent Company stood at -$16.8 million in 2021, then increased by 19.08% to -$13.6 million in 2022, then skyrocketed by 136.54% to $5.0 million in 2023, then tumbled by 98.75% to $62,000 in 2024, then tumbled by 18,396.22% to -$83.2 million in 2025.
  • Its Income towards Parent Company stands at -$83.2 million for Q3 2025, versus -$25.7 million for Q2 2025 and -$23.5 million for Q1 2025.